Medicalgorithmics S.A. provides AI-powered and noninvasive solutions for cardiac diagnostic in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythmAI, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices. The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. In addition, the company engages in research and development services, including algorithm development, clinical studies, software development, consulting services, and medical hardware development; and end-to-end ECG Monitoring for clinical trials. Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
Research context
Medicalgorithmics S.A. appears in PyInvesting’s Warsaw Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- PLN
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Medicalgorithmics S.A. is currently in a long term uptrend where the price is trading 27.0% above its 200 day moving average.
Medicalgorithmics S.A.'s total revenue sank by 40.5% to $25M since the same quarter in the previous year.
Its net income has dropped by 4405.0% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 88.8% to $1M since the same quarter in the previous year.
Based on the above factors, Medicalgorithmics S.A. gets an overall score of 1/5.